Improved control of cisplatin-induced emesis with a combination of high doses of methylprednisolone and metoclopramide: a single-blind randomized trial. 1986

Y Bécouarn, and B B Nguyen, and M David, and F Lakdja, and R Brunet, and J Chauvergne

Forty-seven patients undergoing their first course of chemotherapy containing cisplatin in combination with other drugs were randomized to compare the antiemetic efficacy of high dose metoclopramide vs. high dose methylprednisolone added to metoclopramide. The number of patients who experienced no emetic episodes was significantly higher with the combination regimen (P less than 0.01). In addition, both the mean number of emetic episodes (P = 0.01) and the duration of nauseas (P = 0.025) were decreased with the combination regimen. Both antiemetic regimens were well tolerated. Sex affected the response, with women having more nausea and vomiting than did men (P less than 0.05).

UI MeSH Term Description Entries
D008297 Male Males
D008775 Methylprednisolone A PREDNISOLONE derivative with similar anti-inflammatory action. 6-Methylprednisolone,Medrol,Metipred,Urbason,6 Methylprednisolone
D008787 Metoclopramide A dopamine D2 antagonist that is used as an antiemetic. 4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide,Cerucal,Maxolon,Metaclopramide,Metoclopramide Dihydrochloride,Metoclopramide Hydrochloride,Metoclopramide Monohydrochloride,Metoclopramide Monohydrochloride, Monohydrate,Primperan,Reglan,Rimetin,Dihydrochloride, Metoclopramide,Hydrochloride, Metoclopramide,Monohydrochloride, Metoclopramide
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Y Bécouarn, and B B Nguyen, and M David, and F Lakdja, and R Brunet, and J Chauvergne
January 1984, Cancer chemotherapy and pharmacology,
Y Bécouarn, and B B Nguyen, and M David, and F Lakdja, and R Brunet, and J Chauvergne
February 1991, Zhonghua yi xue za zhi = Chinese medical journal; Free China ed,
Y Bécouarn, and B B Nguyen, and M David, and F Lakdja, and R Brunet, and J Chauvergne
March 1989, Japanese journal of clinical oncology,
Y Bécouarn, and B B Nguyen, and M David, and F Lakdja, and R Brunet, and J Chauvergne
August 1993, American journal of clinical oncology,
Y Bécouarn, and B B Nguyen, and M David, and F Lakdja, and R Brunet, and J Chauvergne
January 1988, Oncology,
Y Bécouarn, and B B Nguyen, and M David, and F Lakdja, and R Brunet, and J Chauvergne
March 1984, Annals of internal medicine,
Y Bécouarn, and B B Nguyen, and M David, and F Lakdja, and R Brunet, and J Chauvergne
January 1991, Oncology,
Y Bécouarn, and B B Nguyen, and M David, and F Lakdja, and R Brunet, and J Chauvergne
February 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Y Bécouarn, and B B Nguyen, and M David, and F Lakdja, and R Brunet, and J Chauvergne
October 1986, European journal of cancer & clinical oncology,
Copied contents to your clipboard!